Grail (NASDAQ:GRAL) Shares Down 4.1% – Time to Sell?

Grail, Inc. (NASDAQ:GRAL)’s share price traded down 4.1% during mid-day trading on Wednesday . The company traded as low as $39.00 and last traded at $39.82. 1,246,067 shares were traded during mid-day trading, an increase of 4% from the average session volume of 1,201,935 shares. The stock had previously closed at $41.54.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on GRAL shares. Wolfe Research assumed coverage on shares of Grail in a research report on Friday, November 15th. They set a “peer perform” rating for the company. Morgan Stanley assumed coverage on shares of Grail in a research note on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 price target on the stock.

Grail Stock Down 1.7 %

The company has a 50 day moving average of $30.38 and a 200 day moving average of $20.69.

Grail (NASDAQ:GRAL) last issued its earnings results on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, beating analysts’ consensus estimates of ($4.41) by $2.55. The business had revenue of $38.25 million during the quarter, compared to analyst estimates of $35.33 million. Equities analysts predict that Grail, Inc. will post -15.15 earnings per share for the current year.

Institutional Investors Weigh In On Grail

A number of large investors have recently made changes to their positions in the stock. FNY Investment Advisers LLC acquired a new position in Grail during the fourth quarter worth $26,000. State of Tennessee Department of Treasury acquired a new stake in shares of Grail during the 4th quarter worth approximately $28,000. Lindbrook Capital LLC purchased a new stake in Grail in the fourth quarter valued at $28,000. Sterling Capital Management LLC acquired a new position in Grail in the fourth quarter valued at about $29,000. Finally, Wellington Shields Capital Management LLC acquired a new position in shares of Grail in the 4th quarter worth approximately $33,000.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.